Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate, through clinical parameters, the comparative efficacy between topical Tobracort ® (tobramycin 0.3% dexamethasone + 1% - Chemistry Lab Union) and TOBRADEX ® (tobramycin 0.3% dexamethasone + 1 % - Alcon Lab), using the percentage of improvement (sustained response rate) at the end of treatment.


Clinical Trial Description

- Evaluation of signs and symptoms during treatment, with a record of individual scores for each parameter;

- Observation and statistical comparison of drug safety, by recording qualitative and quantitative parameters related to adverse effects occurring during treatment. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01227915
Study type Interventional
Source L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Contact
Status Not yet recruiting
Phase Phase 3
Start date February 2011

See also
  Status Clinical Trial Phase
Completed NCT00347932 - A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. Phase 3
Completed NCT00348348 - A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Phase 3
Completed NCT05816070 - Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis Phase 2